Author Archives: Omar Ford

Augmented reality check

My first real exposure to what’s commonly called augmented reality was about a year ago when one of my former colleagues introduced me to Pokemon Go. I remember her telling me that you could actually hold up your smartphone or…

FacebookTwitterGoogle+Share

Edwards Lifesciences is first in mitral valve repair with FDA approval of Sapien 3

By Katie Pfaff Staff Writer Edwards Lifesciences Corp. won FDA approval for its Sapien 3 transcatheter heart valve device for aortic and mitral valve-in-valve procedures. The Irvine, Calif.-based company leads the way in a burgeoning sector of the market with…

FacebookTwitterGoogle+Share

Angiodynamics files antitrust lawsuit against C.R. Bard regarding PICC line

By Omar Ford Staff Writer Angiodynamics Inc. has filed a lawsuit against C.R. Bard Inc., claiming the Murray Hill, N.J.-based company has violated antitrust laws with its catheter tip locators. The lawsuit was filed in the U.S. District Court for…

FacebookTwitterGoogle+Share

Saluda Medical evokes funding from two industry heavyweights in series D round

By Omar Ford Staff Writer Saluda Medical Pty Ltd. is spreading its roots in both the neuromodulation space and the developing bioelectronics medicine market with its latest funding round. The Artarmon, Australia-based company has secured $40 million in an all-equity…

FacebookTwitterGoogle+Share

Cybersecurity on tap for ransomware threat

By Mark McCarty Regulatory Editor The FDA’s latest cybersecurity workshop was inevitably topical, given the rapidly shifting range of threats to device security, but the workshop took place as the Wannacry ransomware crippled hospitals around the world, making this a…

FacebookTwitterGoogle+Share

Endologix exits challenging month, resumes shipment of some AFX devices

By Omar Ford Staff Writer Endologix Inc. has resumed shipping of some of its AFX endovascular abdominal aortic aneurysm systems, after placing the devices on hold. This brought an end to a rather tumultuous week for the Irvine, Calif.-based company’s…

FacebookTwitterGoogle+Share

Abbott Laboratories gets FTC green light to acquire St. Jude Medical

By Omar Ford, Staff Writer The U.S. Federal Trade Commission (FTC) has approved Abbott Laboratories’ $25 billion acquisition of St. Jude Medical Inc. The deal was green lit after the FTC accepted a proposal for the divestiture of St. Jude’s…

FacebookTwitterGoogle+Share

Microport buys rights for Lombard’s stent grafts

By Carmen Ho, Staff Writer HONG KONG – Chinese companies, many with improving technologies, continue to use acquisitions to expand their global market share. A case in point is Shanghai-based Microport Scientific Corp., which inked a $15 million investment in…

FacebookTwitterGoogle+Share

Allergan to pay $2.9B for Lifecell, driven in part by breast cancer

By Michael Fitzhugh, Staff Writer Allergan plc said it will buy Lifecell Corp., a company that makes regenerative medicine products for tissue reinforcement, from privately held Acelity LP for $2.9 billion in cash, a purchase partly driven by growing demand…

FacebookTwitterGoogle+Share

SCA gets deeper into health care with proposed $2.9 billion BSN buy

By Omar Ford, Staff Writer Svenska Cellulosa AB (SCA) has entered into an agreement to acquire Luxembourg, Germany-based BSN Medical Ltd. for about $2.9 billion. The Stockholm, Sweden-based company is acquiring BSN from private equity firm EQT, and the transaction…

FacebookTwitterGoogle+Share

Marketo